Reported segment mix · SEC DERA dimensional facts

VYCOR MEDICAL INC VYCO revenue by segment, product and geography

In its fiscal year ending 2025-12-31, VYCOR MEDICAL INC reported revenue across 2 business segments; the largest, Vycor Medical Inc, was $1.8M, 96.4% of the filed sum (+18.5% against the prior period in the same filing).

Full financial analysis →Company overview →

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing

Fiscal year ending 2025-12-3110-K filed 2026-03-31prior period 2024-12-31 from the same filingView filing

By business segment

Revenue

Vycor Medical Inc$1.8M
96.4%
+18.5% yoy
Nova Vision Inc$67.3K
3.6%
-8.5% yoy

Members sum to the consolidated $1.86M for this period.

Operating income

Vycor Medical Inc$494K
1456.6%
+39.9% yoy
Corporate-$276K
-814.2%
+49.8% yoy
Nova Vision Inc-$184K
-542.4%
+3.4% yoy

Members sum to the consolidated $33.9K for this period.

By geography

Revenue

United States$1.86M
99.7%
+17.2% yoy
Europe$4.91K
0.3%
+33.3% yoy

Members sum to the consolidated $1.86M for this period.

Operating income

United States$335K
988.2%
+67.4% yoy
Corporate-$276K
-814.2%
+49.8% yoy
Europe-$25.1K
-74.0%
+0.4% yoy

Members sum to the consolidated $33.9K for this period.

Latest quarter

Quarter ending 2026-03-3110-Q filed 2026-05-15prior period 2025-03-31 from the same filingView filing

Vycor Medical Inc$440K
96.1%
+5.2% yoy
Nova Vision Inc$18.1K
3.9%
+1.3% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

About these figures

Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.

Descriptive and educational; not investment advice. Methodology and data lineage.